user

Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER plus breast cancer

被引：0
|
作者：
Traphagen, Nicole
Schwartz, Gary
Tau, Steven
Roberts, Alyssa
Jiang, Amanda
Hosford, Sarah
Marotti, Jonathan
Goen, Abigail
Romo, Bianca
Johnson, Anneka
Duffy, Emily
Demidenko, Eugene
Heverly, Paul
Mosesson, Yaron
Soucy, Shannon
Kolling, Fred
Miller, Todd
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO4-23-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO4-23-08
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER plus Breast Cancer
    Traphagen, Nicole A.
    Schwartz, Gary N.
    Tau, Steven
    Roberts, Alyssa M.
    Jiang, Amanda
    Hosford, Sarah R.
    Marotti, Jonathan D.
    Goen, Abigail E.
    Romo, Bianca A.
    Johnson, Anneka L.
    Duffy, Emily-Claire K.
    Demidenko, Eugene
    Heverly, Paul
    Mosesson, Yaron
    Soucy, Shannon M.
    Kolling, Fred
    Miller, Todd W.
    [J]. CLINICAL CANCER RESEARCH, 2023, 29 (18) : 3717 - 3728
  • [2] Estrogen therapy induces R-loop-dependent DNA damage that can be enhanced by PARP inhibition to improve response in ER plus breast cancer
    Traphagen, Nicole A.
    Tau, Steven
    Jiang, Amanda
    Wells, Jason D.
    Hosford, Sarah R.
    Goen, Abigail E.
    Demidenko, Eugene
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [3] PARP inhibition effects on endocrine therapy and resistance in estrogen receptor positive (ER plus ) breast cancer models
    Nardone, Agostina
    Goldstein, Amit
    Shea, Martin J.
    Mithchell, Tamika
    Fu, Xiaoyong
    De Angelis, Carmine
    Hu, Huizhong
    Xu, Xiaowei
    Rajendran, Mahitha
    O'Connor, Mark
    Locker, Gershon
    Hilsenbeck, Susan
    Osborne, Kent
    Schiff, Rachel
    [J]. CANCER RESEARCH, 2015, 75
  • [4] Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis
    Yue, Wei
    Yager, James D.
    Wang, Ji-Ping
    Jupe, Eldon R.
    Santen, Richard J.
    [J]. STEROIDS, 2013, 78 (02) : 161 - 170
  • [5] Estrogen receptor is a target of enzalutamide in ER plus breast cancer
    Wei, Lixuan
    Yu, Jia
    Gao, Huanyao
    Zhang, Huan
    Nguyen, Thanh
    Gu, Yayun
    Weinshilboum, Richard M.
    Ingle, James N.
    Wang, Liewei
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [6] Estrogen receptor inhibition with tamoxifen mediates radiosensitization of ER plus breast cancer models.
    Michmerhuizen, Anna R.
    Pesch, Andrea M.
    Schwartz, Rachel
    Wilder-Romans, Kari
    Liu, Meilan
    Azaria, Ruth
    Jelley, Alexa
    Pierce, Lori J.
    Speers, Corey W.
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [7] Epigenetic mechanisms of cancer progression and therapy resistance in estrogen-receptor (ER plus ) breast cancer
    Toska, Eneda
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (03):
  • [8] Estrogen therapy induces an unfolded protein response to drive cell death in ER plus breast cancer
    Hosford, Sarah R.
    Shee, Kevin
    Wells, Jason D.
    Traphagen, Nicole A.
    Fields, Jennifer L.
    Hampsch, Riley A.
    Kettenbach, Arminja N.
    Demidenko, Eugene
    Miller, Todd W.
    [J]. MOLECULAR ONCOLOGY, 2019, 13 (08) : 1778 - 1794
  • [9] DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer
    Awada, Z.
    Nasr, R.
    Akika, R.
    Cahais, V.
    Cuenin, C.
    Zhivagui, M.
    Herceg, Z.
    Ghantous, A.
    Zgheib, N. K.
    [J]. CLINICAL EPIGENETICS, 2019, 11 (01)
  • [10] Inhibition of estrogen receptor signaling as a strategy for radiosensitization of ER plus breast cancers
    Michmerhuizen, Anna R.
    Lerner, Lynn M.
    Pesch, Andrea M.
    Ward, Connor
    Schwartz, Rachel
    Wilder-Romans, Kari
    Liu, Meilan
    Nino, Charles
    Jungles, Kassidy
    Azaria, Ruth
    Jelley, Alexa
    Garcia, Nicole Zambrana
    Harold, Alexis
    Zhang, Amanda
    Wharram, Bryan
    Hayes, Daniel F.
    Rae, James M.
    Pierce, Lori J.
    Speers, Corey W.
    [J]. CANCER RESEARCH, 2022, 82 (12)
12345